1. Home
  2. APYX vs BEAT Comparison

APYX vs BEAT Comparison

Compare APYX & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • BEAT
  • Stock Information
  • Founded
  • APYX 1982
  • BEAT 2015
  • Country
  • APYX United States
  • BEAT United States
  • Employees
  • APYX N/A
  • BEAT N/A
  • Industry
  • APYX Medical/Dental Instruments
  • BEAT Retail: Computer Software & Peripheral Equipment
  • Sector
  • APYX Health Care
  • BEAT Technology
  • Exchange
  • APYX Nasdaq
  • BEAT Nasdaq
  • Market Cap
  • APYX 66.5M
  • BEAT 51.1M
  • IPO Year
  • APYX 1987
  • BEAT 2021
  • Fundamental
  • Price
  • APYX $2.25
  • BEAT $1.35
  • Analyst Decision
  • APYX Hold
  • BEAT Buy
  • Analyst Count
  • APYX 2
  • BEAT 1
  • Target Price
  • APYX N/A
  • BEAT $8.00
  • AVG Volume (30 Days)
  • APYX 72.0K
  • BEAT 175.9K
  • Earning Date
  • APYX 08-07-2025
  • BEAT 08-13-2025
  • Dividend Yield
  • APYX N/A
  • BEAT N/A
  • EPS Growth
  • APYX N/A
  • BEAT N/A
  • EPS
  • APYX N/A
  • BEAT N/A
  • Revenue
  • APYX $47,288,000.00
  • BEAT N/A
  • Revenue This Year
  • APYX $2.25
  • BEAT N/A
  • Revenue Next Year
  • APYX $6.76
  • BEAT N/A
  • P/E Ratio
  • APYX N/A
  • BEAT N/A
  • Revenue Growth
  • APYX N/A
  • BEAT N/A
  • 52 Week Low
  • APYX $0.76
  • BEAT $1.21
  • 52 Week High
  • APYX $2.30
  • BEAT $3.48
  • Technical
  • Relative Strength Index (RSI)
  • APYX 62.48
  • BEAT 37.47
  • Support Level
  • APYX $1.84
  • BEAT $1.49
  • Resistance Level
  • APYX $2.29
  • BEAT $1.62
  • Average True Range (ATR)
  • APYX 0.21
  • BEAT 0.11
  • MACD
  • APYX 0.02
  • BEAT -0.02
  • Stochastic Oscillator
  • APYX 84.09
  • BEAT 7.44

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: